An AI-designed universal coronavirus vaccine has passed its first human trial
A new universal coronavirus vaccine has completed its first human clinical trial, representing a key advance toward broader protection against future outbreaks. Researchers at the University of Cambridge and the spinout company DIOSynVax (DVX) Ltd developed the experimental vaccine and tested it on 39 healthy volunteers, finding it to be safe with no serious side […]
An AI-designed universal coronavirus vaccine has passed its first human trial Read More »









